Ò»¾º¼¼

English Ò»¾º¼¼¼¯ÍÅÆóÒµÓÊÏä

ÌìÏÂÉúÃü¿ÆÑ§Ç°Ñض¯Ì¬Öܱ¨£¨Ê®£©

2010Äê-05ÔÂ-30ÈÕ ÈªÔ´£ºmebo

£¨05.24--05.30 / 2010£©
Ò»¾º¼¼¹ú¼Ê¼¯ÍÅ:ÌÕ¹úР 
 

¡¡¡¡±¾Öܶ¯Ì¬°üÀ¨ÒÔÏÂÄÚÈÝ£ºÐÂÐÍDNA¿¹°©ÒßÃç; Ê״η¢Ã÷¿É·¢Óý³ÉÂѵĸÉϸ°û; Ö¬·¾¸Éϸ°û·Ö½âΪÐļ¡Ï¸°û; CD95 Ôö½øÖ×ÁöÉú³¤ £»ºËÌǺËËá×ÌÈÅ¿ÉÒÖÖÆ°©Ö¢»îÔ¾»ùÒò £»ÈËÌå¸Éϸ°ûÀÖ³ÉÔì³öÈ˹¤ÑÀ³Ý¡£

1. ÐÂÐÍDNA¿¹°©ÒßÃç

¡¾ÕªÒª¡¿Ð»ªÍø Ðû²¼Ê±¼ä£º2010-5-25 16:44:42
Èðµä¿¨ÂÞÁÖ˹¿¨Ò½Ñ§ÔºÈÕǰ½ÒÏþͨ¸æËµ £¬¸Ã»ú¹¹Ñо¿Ö°Ô±ÑÐÖÆ³öÒ»ÖÖ¿ÉÒÖÖÆ¶ñÐÔÖ×ÁöÉú³¤µÄÐÂÐÍDNA£¨ÍÑÑõºËÌǺËËᣩÒßÃç £¬ÊµÑéÏÔʾÕâÖÖÒßÃçÎÞ¸±×÷Óᣵ±¶ñÐÔÖ×ÁöÁè¼Ý¼¸¸öºÁÃ×ʱ £¬ÐèÒªÐγÉеÄѪ¹ÜΪÖ×ÁöÌá¹©ÓªÑøºÍÑõÆø¡£Òò´Ë £¬×èֹѪ¹ÜµÄÉú³¤ÊÇÖÎÁƶñÐÔÖ×ÁöµÄ˼Ð÷Ö®Ò»¡£ÂѰ×ÖÊDLL4ÊÇÐγÉѪ¹ÜµÄÐëÒªÒòËØ £¬ÈôÊÇÄÜÒÖÖÆÖ×Áöϸ°ûÖеÄDLL4ÂѰ×ÖÊ £¬½«Ê¹ÐÂѪ¹Üʧȥ¹¦Ð§ £¬´Ó¶ø´ó´ó¼õ»ºÖ×ÁöµÄÉú³¤ËÙÂÊ¡£
Ñо¿Ö°Ô±¾Ý´ËÑÐÖÆ³öÁËÕâÖÖDNAÒßÃç¡£¾­¶Ô»¼ÓÐÈéÏÙ°©µÄС°×Êó¾ÙÐÐÊÔÑé £¬Ö¤Êµ½ÓÖÖÒßÃçµÄС°×ÊóÌåÄÚ±¬·¢ÁË¿ÉÒÖÖÆDLL4ÂѰ×ÖʵĿ¹Ìå £¬×èÖ¹ÁËÌåÄÚÈéÏÙÖ×ÁöµÄÉú³¤ £¬²¢ÇÒûÓÐÒýÆðÈκβ»Á¼·´Ó¦ £¬Ò²Î´Ó°ÏìС°×ÊóµÄÉË¿ÚÓúºÏ¡£Ñо¿Ö°Ô±Æ¤Ò®ÌØÀ­Ë¹³Æ £¬Ñ¡ÔñÈéÏÙ°©×÷ΪÊÔÑéÄ¿µÄÊÇÓÉÓÚÈéÏÙÖ×Áö´øÓдó×ÚµÄDLL4ÂѰ×ÖÊ¡£Ñо¿Ö°Ô±Ï£ÍûÄܽ«ÕâÖÖÒßÃçÓÃÓÚÈéÏÙ°©µÄÊõºóÖÎÁÆ £¬±ÜÃâÖ×Áö¸´·¢¡£
¡¾µãÆÀ¡¿ µãÆÀ£ºÐ¡Êóͨ¹ý½ÓÖÖDNAÒßÃç £¬±¬·¢¿¹ÌåÒÖÖÆ¶ñÐÔÖ×ÁöÐÂÉúѪ¹Ü±ØÐèµÄDLL4ÂѰ×ÖÊ £¬´Ó¶ø×èÖ¹Ö×ÁöÉú³¤¡£¸ÃÒßÃç¹ØÓÚ¼õ»ºÖ×ÁöÉú³¤ºÍ±ÜÃâÖ×Áö¸´·¢¿ÉÄÜÓÐ×÷Óà £¬¿ÉÊÇÓÉÓÚ²»¿ÉÖ±½Ó×÷ÓÃÓÚÖ×Áöϸ°û £¬»¹²»¿ÉÄܸù³ý°©Ö¢¡£

¡¾Ô­ÎÄժ¼¡¿Oncogene , (24 May 2010) | doi:10.1038/onc.2010.176
Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like 4 in mammary carcinoma
BK Haller, A Bråve, E Wallgard, P Roswall, VG Sunkari, U Mattson, D Hallengärd, S-B Catrina, M Hellström och K Pietras
The Notch ligand delta-like ligand 4 (DLL4) is an essential component expressed by endothelial tip cells during angiogenic sprouting. We have described a conceptually novel therapeutic strategy for targeting tumor angiogenesis and endothelial tip cells based on DNA vaccination against DLL4. Immunization with DLL4-encoding plasmid DNA by in vivo electroporation severely retarded the growth of orthotopically implanted mammary carcinomas in mice by induction of a nonproductive angiogenic response. Mechanistically, vaccination brought about a break in tolerance against the self-antigen, DLL4, as evidenced by the production of inhibitory and inherently therapeutic antibodies against mouse DLL4. Importantly, no evidence for a delayed wound healing response, or for toxicity associated with pharmacological blockade of DLL4 signaling, was noted in mice immunized with the DLL4 vaccine. We have thus developed a well-tolerated DNA vaccination strategy targeting the endothelial tip cells and the antigen DLL4 with proven therapeutic efficacy in mouse models of mammary carcinoma; a disease that has been reported to dramatically induce the expression of DLL4. Conceivably, induction of immunity toward principal mediators of pathological angiogenesis could provide protection against recurrent malignant disease in the adjuvant setting.

 

2. Ê״η¢Ã÷¿É·¢Óý³ÉÂѵĸÉϸ°û

¡¾ÕªÒª¡¿Ð»ªÍø 2010-5-25 9:39:40
ÈÕ±¾Ò»¸öÑо¿Ð¡×éÈÕǰ·¢Ã÷ £¬ÔÚ´Æ÷šÓãµÄÂѳ²ÄÚ±£´æ¿É·¢Óý³É÷šÓãÂѵĸÉϸ°û¡£ÓйØÐ§¹ûÒѾ­¿¯µÇÔÚ×îÐÂÒ»ÆÚµÄÃÀ¹ú¡¶¿ÆÑ§¡·ÔÓÖ¾ÍøÂç°æÉÏ¡£ÕâһЧ¹ûÊÇÈÕ±¾×ÔÈ»¿ÆÑ§Ñо¿»ú¹¹»ù´¡ÉúÎïѧÑо¿ËùµÄÑо¿Ö°Ô±»ñµÃµÄ¡ £»ù´¡ÉúÎïѧÑо¿ËùÈÕǰ½ÒÏþͨ¸æËµ £¬ÔÚ¼¹×µ¶¯ÎïÖÐ £¬ÒѾ­·¢Ã÷ÐÛÐԵľ«³²Öб£´æ·¢Óý³É¾«×ӵĸÉϸ°û £¬¿ÉÊÇÔÚÂѳ²Öз¢Ã÷»á·¢Óý³ÉÂѵĸÉϸ°ûÔòÊôÌìÏÂÊ״Ρ£Ñо¿Ð¡×é¶Ô´ÆÐÔ÷šÓã¾ÙÐлùÒò²Ù×÷ £¬Ê¹ÆäÂѳ²ÄÚµÄÂÑ·¢³öºì¹â £¬Ð§¹û·¢Ã÷ÁËÐí¶à¼´½«·¢ÓýΪÂѵÄϸ°û¡£Ê¹ÓÃÂÌɫӫ¹âÂѰ×ÖʸøÕâЩϸ°û×öÉϱê¼ÇÒÔºó £¬Ñо¿Ö°Ô±·¢Ã÷Ðí¶àÐÂÐγɵÄÂÑÒ²»á·¢³öÂÌɫӫ¹â £¬Õâ˵Ã÷ÕâЩϸ°û¼òÖ±·¢Óý³ÉÁËÂÑ £¬Òò´ËÕâЩϸ°û¾ÍÊǸÉϸ°û¡£
¡¾µãÆÀ¡¿ µãÆÀ£ºÌìÏÂÊ×´ÎÔÚ¼¹×µ¶¯ÎïÂѳ²Öз¢Ã÷»á·¢Óý³ÉÂѵĸÉϸ°û¡£ÓÉÓÚûÓÐÖ±½ÓÖ¤¾ÝÏÔʾ³ÉÌå¼¹×µ¶¯ÎïÂѳ²ÖÐÓÐÉúÖ³¸Éϸ°û £¬ÕâЩ·¢Óý³ÉÂѵĸÉϸ°ûºÜ¿ÉÄÜÊÇ´ÓÂѳ²ÖеÄÌåϸ°ûԭλת±äµÄ¡£

¡¾Ô­ÎÄժ¼¡¿Science DOI: 10.1126/science.1185473
Identification of Germline Stem Cells in the Ovary of the Teleost Medaka
Shuhei Nakamura,1 Kayo Kobayashi,1 Toshiya Nishimura,1,2 Shin-ichi Higashijima,3,4 Minoru Tanaka1,2,*

Germline stem cells continually produce sperm in vertebrate testes, whereas there is no direct evidence showing that germline stem cells are present in adult vertebrate ovaries. Using transgenic methods and clonal analysis, we identified germline stem cells that supported oogenesis and the production of offspring in the ovaries of adult medaka fish. Early-stage germ cells were localized in clusters along interwoven threadlike cords of sox9b-expressing somatic cells (termed "germinal cradles") where the germ cells developed. Germline stem cells gave rise to germ cells that divided to produce cysts, which then underwent cell death or separated to form follicles. Our results provide insight into germline stem cell biology of medaka and provide a model system for studying vertebrate stem cell niches. 
 

3. Ö¬·¾¸Éϸ°û·Ö½âΪÐļ¡Ï¸°û

¡¾ÕªÒª¡¿Î÷°àÑÀÑо¿Ö°Ô±Ê״δÓÈËÀàÖ¬·¾×éÖ¯ÖÐÊèÉ¢³ö³ÉÊìµÄ¸Éϸ°û £¬ÈÃÕâЩϸ°ûÔÝʱ̻¶ÓÚÈËÀàµÄÐÄ·¿Ï¸°ûÖÐ £¬ËæºóÔÙ¶ÔÕâЩϸ°ûÖØÐ¾ÙÐÐ×÷Óý¡£¾­ÓÉ12ÌìµÄ×÷Óý £¬ÕâЩϸ°ûÏò×ÅÐļ¡Ï¸°ûµÄ±íÐÍÆ«Ïò·Ö½â £¬Õâ¿ÉÒÔͨ¹ýÒÔÏ·½Ãæ»ñµÃ֤ʵ£ºÕâЩϸ°û´ÓÐÎ̬Éϱ¬·¢Á˸ıä £¬ÌåÏÖΪ´øÓÐÏËÎ¬ÎÆºÍ·ÖÖ¦µÄË«ºËϸ°û £»ÃâÒßÓ«¹â¼ì²é·¢Ã÷ £¬ËüÃÇ´øÓÐÐÄÔàÌØÓеıê¼Ç £»RT  -  PCR¼ì²â֤ʵ £¬ÕâЩϸ°û±£´æÐļ¡»ùÒò £»ËüÃÇÓÐÄæ×ªÂ¼±í´ï¡£ÕâÑù £¬ÕâЩ¸Éϸ°û»ñµÃÁËÒ»¸öÐÄÔàµÄ±íÐÍ¡£Î´À´¿Éͨ¹ýÕâÏîÊÖÒÕ´Ó»¼ÕßÉíÉÏÖ±½ÓÌáȡϸ°ûÀ´ÔÙÉúÐļ¡Ï¸°û¡£¿ÉÊÇÒ½ÉúÃÇÌåÏÖ £¬ÏÖÔÚÕâÏîÑо¿»¹´¦ÓÚ³õÆÚ½×¶Î £¬ÒªÓÃÓÚÖÎÁÆÉÐÓкܳ¤Ò»¶Îʱ¼ä¡£
¡¾µãÆÀ¡¿ µãÆÀ£º¸Éϸ°û·Ö½âµÄ¾öÒéÊܵ½ÆäËù´¦ÐÄÀíÇéÐεĵ÷¿Ø £¬ÕâÀàµ÷¿ØÒ²¾öÒéÁËÆäÔÚÌåÍâ×÷ÓýʱµÄ·Ö½âÆ«Ïò¡£

¡¾Ô­ÎÄժ¼¡¿Cytotherapy DOI: 10.3109/14653240903548202

Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes
Background aims. The goal was to induce the transdifferentiation (or conversion) of human adipose-derived stem cells to cardiomyocytes using an intracellular extract obtained from adult human heart tissue. Methods. Human adult stem cells from lipoaspirates were transiently permeabilized, exposed to human atrial extracts and allowed to recover in culture. Results. After 21 days, the cells acquired a cardiomyocyte phenotype, as demonstrated by morphologic changes (appearance of binucleate, striated cells and branching fibers), immunofluorescence detection of cardiac-specific markers (connexin-43, sarcomeric ¦Á-actinin, cardiac troponin I and T, and desmin) and the presence of cardiomyocyte-related genes analyzed by reverse transcription¨Cpolymerase chain reaction (cardiac myosin light chain 1, ¦Á-cardiac actin, cardiac troponin T and cardiac ¦Â-myosin). Conclusions. We have demonstrated for the first time that adult cardiomyocytes obtained from human donors retain the capacity to induce cardiomyocyte differentiation of mesenchymal stromal cells. The use of autologous extracts for reprogramming adult stem cells may have potential therapeutic implications for treating heart disease.


4. CD95 Ôö½øÖ×ÁöÉú³¤

¡¾ÕªÒª¡¿CD95 Ô­À´Ò»Ö±±»ÒÔΪÊǵòÍöÊÜÌåÂѰ× £¬Í¨¹ýÓÕµ¼Ï¸°ûµòÍöÀ´µ÷Àí×éÖ¯ÄÚÎÈ̬ £¬Êǰ©Ï¸°ûɱÊÖ¡£ÏÖÔÚ·¢Ã÷ £¬×ÔÏàì¶ÜµÄÊÇ £¬°©Ï¸°ûµÄÕý³£Éú³¤Ò²Àë²»¿ªËü¡£Ã»ÓÐËü £¬Ð¡ÊóµÄÂѳ²°©ºÍ¸Î°©·¢²¡ÂʺÍÖ×ÁöÌå»ý¶¼½µµÍÁË¡£
¡¾µãÆÀ¡¿ µãÆÀ£º·¢Ã÷CD95 ÊÜÌåÂѰ×ÔÚ°©Ö¢Éú³¤ÖÐÓÐÔö½ø×÷Óà £¬ÔÚ°©Ö¢ÖÎÁÆÖÐÓ¦¸ÃÒÖÖÆÆä»îÐÔ¶ø·ÇÔ­À´ÒÔΪµÄÔöÇ¿Æä»îÐÔ¡£

¡¾Ô­ÎÄժ¼¡¿Nature 465, 492¨C496 (27 May 2010) doi:10.1038/nature09075

CD95 promotes tumour growth
Lina Chen, Sun-Mi Park, Alexei V. Tumanov, Annika Hau, Kenjiro Sawada, Christine Feig, Jerrold R. Turner, Yang-Xin Fu, Iris L. Romero, Ernst Lengyel & Marcus E. Peter
CD95 (also called Fas and APO-1) is a prototypical death receptor that regulates tissue homeostasis mainly in the immune system through the induction of apoptosis1, 2, 3. During cancer progression CD95 is frequently downregulated or cells are rendered apoptosis resistant4, 5, raising the possibility that loss of CD95 is part of a mechanism for tumour evasion. However, complete loss of CD95 is rarely seen in human cancers4 and many cancer cells express large quantities of CD95 and are highly sensitive to CD95-mediated apoptosis in vitro. Furthermore, cancer patients frequently have elevated levels of the physiological ligand for CD95, CD95L6. These data raise the possibility that CD95 could actually promote the growth of tumours through its non-apoptotic activities7. Here we show that cancer cells in general, regardless of their CD95 apoptosis sensitivity, depend on constitutive activity of CD95, stimulated by cancer-produced CD95L, for optimal growth. Consistently, loss of CD95 in mouse models of ovarian cancer and liver cancer reduces cancer incidence as well as the size of the tumours. The tumorigenic activity of CD95 is mediated by a pathway involving JNK and Jun. These results demonstrate that CD95 has a growth-promoting role during tumorigenesis and indicate that efforts to inhibit its activity rather than to enhance it should be considered during cancer therapy.
 

5. ºËÌǺËËá×ÌÈÅ¿ÉÒÖÖÆ°©Ö¢»îÔ¾»ùÒò

¡¾ÕªÒª¡¿2010Äê05ÔÂ29ÈÕ 09:15:13 ¡¡ÈªÔ´£º ¿Æ¼¼ÈÕ±¨
¼ÓÄôóÂ󼪶û´óѧÉúÎﻯѧϵÑо¿Ö°Ô±·¢Ã÷ £¬ÓëºËÌǺËËáÏàÍŽáµÄÒ»ÖÖÂѰ×ÖÊÆ¬¶ÏÄܹ»¿ØÖÆ»ùÒòµÄÕý³£±í´ï £¬ÆäÖаüÀ¨ÄÇЩÔÚ°©Ö¢ÖлîÔ¾µÄ»ùÒò¡£×¨¼ÒÒÔΪ £¬ÕâÊǰ©Ö¢Ñо¿ÊÂÇéµÄÒ»ÏîÖ÷ÒªÍ»ÆÆ £¬¿ÉÁ¬Ã¦½«ÆäÓ¦Óõ½ÊµÑéÊÒµÄÑо¿ÊÂÇéÖÐ £¬²¢ÇÒʹÏÖÔÚ¸÷¹ú¿ÆÑ§¼ÒÆÕ±é¿ªÕ¹µÄ°©Ö¢¸öÐÔ»¯ÖÎÁÆÊÂÇéÏòÇ°ÍÆ½øÁËÒ»´ó²½¡£Ïà¹ØÑо¿Ð§¹û½ÒÏþÔÚ5ÔÂ26ÈÕ¡¶×ÔÈ»¡·ÔÓÖ¾ÍøÂç°æÉÏ¡£ÈËÀàϸ°ûÐèÒªÔÚºÏÊʵÄʱ¼äÉú²ú³öÊʶÈÊýÄ¿µÄÕý³£ÂѰ×ÒÔά³ÖÆä¿µ½¡¡£Ï¸°û¶ÔÂѰ×Éú²ú¾ÙÐÐÓÐÓÿØÖÆÊ± £¬Ëù½ÓÄɵÄÖ÷ÒªÊÖ¶ÎÖ®Ò»¾ÍÊÇÒÀÀµ¡°ºËÌǺËËá×ÌÈÅ¡±¡£¡°ºËÌǺËËá×ÌÈÅ¡±ÊÇ»ùÒò¾²Ä¬µÄÒ»ÖÖÐÎʽ £¬¼´Ð¡Æ¬¶ÏºËÌǺËËᣨÓÖ³ÆÎ¢ºËÌǺËËᣩÓëËüÃǵÄÒÅ´«ÃÜÂëÍŽá £¬ÒÔ×è¶ÏÌØÊâÂѰ׵ÄÉú²ú¡£È»¶ø £¬²»ÊǺËÌǺËËáµÄÈÎºÎÆ¬¶Ï¶¼Äܹ»°´´Ë·½·¨ÐÐÊ¡£
Â󼪶û´óѧµÄ¹þÉ£¡¤À­¼Ö¶û²©Ê¿ÓëͬʺÏ×÷ £¬Ê¹ÓýṹÉúÎïѧ½Ò¿ªÁËArgonauteÂѰ×ÖеÄһС¶Î £¬¼´¡°ºËÌǺËËá×ÌÈÅ¡±µÄÒªº¦·Ö×ÓÔõÑùÄܹ»Ñ¡Ôñ׼ȷµÄ΢ºËÌǺËËáµÄÉñÃØ¡£Ñо¿Ö°Ô±·¢Ã÷ £¬¡°ºËÌǺËËá×ÌÈÅ¡±¿ÉÒÔ´ÙʹArgonauteÂѰ×ÔöÌí»ùÒò¾²Ä¬¡£À­¼Ö¶û²©Ê¿ÒÔΪ £¬¡°ºËÌǺËËá×ÌÈÅ¡±¿ÉÒÔ×÷Ϊ¿ÉÐеÄÖÎÁÆÒªÁì £¬À´ÒÖÖÆÄÇЩÔÚ°©Ö¢µÈ¼²²¡ÖÐÏÔµÃÌØÊâ»îÔ¾µÄÌØÊâ»ùÒò¡£ËûÌåÏÖÏÖÔÚÒѾ­ÕÆÎÕÁËÐÞ¸Ä΢ºËÌǺËËáµÄÒªÁì £¬¿ÉÒÔʹÆä¸ü¾ßЧÁ¦ £¬²¢ÓÐÏ£Íû»ùÓÚ´Ë¿ª·¢³öÖÎÁÆÒ©Îï¡£Ñо¿Ö°Ô±ÒÔΪ £¬¸Ã·¢Ã÷Òª½øÈëÏÖʵÖÎÁÆ»¹ÐèʱÈÕ £¬µ«ËüΪÓÐÄ¿µÄµØ¿ØÖÆÄÇЩ·ÇÕý³£ÂѰ׵ÄÉú²úÌṩÁËÓÐÓÃÒªÁì¡£Â󼪶û´óѧÉú»¯ÏµÖ÷ÈÎÌÀķ˹²©Ê¿ÒÔΪ £¬Ò½Ñ§½çÒ»Ö±ÆÚÅÎÓг¯Ò»ÈÕ¿ÉÒÔ¿¢ÊÂÒÀÀµ»¯ÁÆÒªÁìÖÎÁư©Ö¢ £¬¶ø¸ÃÏî·¢Ã÷³¯×Ű©Ö¢»¼Õ߸öÐÔ»¯»ùÒòÖÎÁÆÆ«ÏòÂõ³öÁËÖ÷ÒªµÄÒ»²½¡££¨¼ÇÕß¶Å»ª±ó£©
¡¾µãÆÀ¡¿ µãÆÀ£ººËÌǺËËá×ÌÈÅ£¨RNAi£©ÊÇ¿ÉÐеÄÒÖÖÆÄÇЩÔÚ°©Ö¢µÈ¼²²¡ÖÐÌØÊâ»îÔ¾µÄÌØÊâ»ùÒòµÄÒªÁì £¬µ«Ö»ÊÇÔÝʱ¹Ø±ÕÕâÀà»ùÒò¶ø²»¿ÉÏû³ýµ¼ÖÂÆäÌØÊâ»îÔ¾µÄÒòËØ £¬ºÜÄѸù³ý°©Ö¢¡£
  
¡¾Ô­ÎÄժ¼¡¿Nature advance online publication 26 May 2010 | doi:10.1038/nature09039
Structural basis for 5¡ä-nucleotide base-specific recognition of guide RNA by human AGO2
Filipp Frank1,2,3, Nahum Sonenberg1,2 & Bhushan Nagar1,3

MicroRNAs (miRNAs) mediate post-transcriptional gene regulation through association with Argonaute proteins (AGOs)1. Crystal structures of archaeal and bacterial homologues of AGOs have shown that the MID (middle) domain mediates the interaction with the phosphorylated 5¡ä end of the miRNA guide strand and this interaction is thought to be independent of the identity of the 5¡ä nucleotide in these systems2,3. However, analysis of the known sequences of eukaryotic miRNAs and co-immunoprecipitation experiments indicate that there is a clear bias for U or A at the 5¡ä position4,5,6,7. Here we report the crystal structure of a MID domain from a eukaryotic AGO protein, human AGO2. The structure, in complex with nucleoside monophosphates (AMP, CMP, GMP, and UMP) mimicking the 5¡ä end of miRNAs, shows that there are specific contacts made between the base of UMP or AMP and a rigid loop in the MID domain. Notably, the structure of the loop discriminates against CMP and GMP and dissociation constants calculated from NMR titration experiments confirm these results, showing that AMP (0.26 mM) and UMP (0.12 mM) bind with up to 30-fold higher affinity than either CMP (3.6 mM) or GMP (3.3 mM). This study provides structural evidence for nucleotide-specific interactions in the MID domain of eukaryotic AGO proteins and explains the observed preference for U or A at the 5¡ä end of miRNAs.
 

6. ÈËÌå¸Éϸ°ûÀÖ³ÉÔì³öÈ˹¤ÑÀ³Ý

¡¾ÕªÒª¡¿ÍøÒ×̽Ë÷2010-5-28 5:18:39
¸çÂ×±ÈÑÇ´óѧҽѧÖÐÐÄ5ÔÂ25ÈÕÐû²¼ÑÀ³ÝÔÙÍâÐÐÒÕ»ñµÃÐÂÍ»ÆÆ £¬Ñо¿Ö°Ô±ÀÖ³ÉÔÚ¶¯Îï¿ÚÇ»ÄÚ¾ÙÐÐÁËÑÀ³ÝÔÙÉúʵÑé £¬ÕâÒâζ×ÅδÀ´ÈËÃǾͿɽ«¸ÃÊÖÒÕÓ¦ÓÃÓÚÁÙ´²ÊµÑéÁìÓò¡£
½ÜÈðÃס¤Ã«£¨Jeremy  Mao£©²©Ê¿ÈÏÕæÏòµ¼¸çÂ×±ÈÑÇ´óѧҽѧÖÐÐÄ×éÖ¯¹¤³Ìѧ¼°ÔÙÉúÒ©ÎïʵÑéÊÒµÄÑо¿Ö°Ô±´ÓʸÿÎÌâµÄÑо¿ £¬ËûÃÇÕÒµ½Ò»ÖÖеÄÊÖÒÕ £¬Ö»ÐèÔÚ»¼Õß¿ÚÇ»ÄÚÖ²ÈëÒ»¸öÍмÜ £¬²¢½«»¼ÕßÌåÄڵĸÉϸ°ûÖ¸µ¼ÖÁÐèÒªÑÀ³ÝÔÙÉúµÄµØ·½ £¬¾Í¿ÉÒÔʵÏÖÕæÕýÒâÒåÉϵġ°ÑÀ³ÝÔÙÉú¡±¡£ÓÃÓÚÖ²È뻼Õß¿ÚÇ»µÄÍмܽ«ËùÓнÓÄÉ×ÔÈ»ÖÊÁÏÖÆ³É £¬²¢½«±»°²ÅÅÔÚʧȥÑÀ³ÝµÄÑÀ¶´ÄÚ¡£ÔÚÉú³¤µÄÀú³ÌÖÐ £¬¸ÃÍмܽ«ÓëÆäÖÜΧµÄÑÀ¶´×éÖ¯Öð½¥ÈÚºÏ £¬ÉõÖÁ»¹»áÁîÑÀÖÜÈÍ´ø¼°³Ý²Û¹ÇÔÙÉú¡£¶øÕâЩÕýÊǹŰåÖÖÑÀÒªÁìËùÎÞ·¨´øÀ´µÄ¡£
¡¾µãÆÀ¡¿ µãÆÀ£º¸Éϸ°û·Ö½âµÄ¾öÒéÊܵ½ÆäËù´¦ÐÄÀíÇéÐεĵ÷¿Ø £¬ÔÚûÓÐÒÆÖ²Ï¸°ûµÄÇéÐÎÏ £¬ÔÚÑÀ³ÝÍмܺÍÔÙÉúÓÕµ¼ÎïµÄ×÷ÓÃÏ £¬ÌåÄÚϸ°ûǨáã¹ýÀ´ÔÙÉúÐÂÑÀ³Ý¡£

¡¾Ô­ÎÄժ¼¡¿Journal of Dental Research, May 2010; vol. 0: pp. 0022034510370803v1.
Anatomically Shaped Tooth and Periodontal Regeneration by Cell Homing

K. Kim, C.H. Lee, B.K. Kim, and J.J. Mao
Tooth regeneration by cell delivery encounters translational hurdles. We hypothesized that anatomically correct teeth can regenerate in scaffolds without cell transplantation. Novel, anatomically shaped human molar scaffolds and rat incisor scaffolds were fabricated by 3D bioprinting from a hybrid of poly--caprolactone and hydroxyapatite with 200-¦Ìm-diameter interconnecting microchannels. In each of 22 rats, an incisor scaffold was implanted orthotopically following mandibular incisor extraction, whereas a human molar scaffold was implanted ectopically into the dorsum. Stromal-derived factor-1 (SDF1) and bone morphogenetic protein-7 (BMP7) were delivered in scaffold microchannels. After 9 weeks, a putative periodontal ligament and new bone regenerated at the interface of rat incisor scaffold with native alveolar bone. SDF1 and BMP7 delivery not only recruited significantly more endogenous cells, but also elaborated greater angiogenesis than growthfactor-free control scaffolds. Regeneration of tooth-like structures and periodontal integration by cell homing provide an alternative to cell delivery, and may accelerate clinical applications.

ÍøÕ¾µØÍ¼